Omalizumab for previously treated chronic spontaneous urticaria

Supporting evidence

• Review decision

• Review decision - July 2018

• Review decision paper (PDF 467 KB)

  Published:

  12 July 2018

• Matrix of stakeholders (PDF 216 KB)

  Published:

  12 July 2018